Your browser doesn't support javascript.
loading
A case-control study of risk factors for intussusception among infants in eastern France after the introduction of the rotavirus vaccine.
Fotso Kamdem, Arnaud; Vidal, Chrystelle; Pazart, Lionel; Leroux, Franck; Pugin, Aurore; Savet, Caroline; Sainte-Claire Deville, Geoffroy; Guillemot, Didier; Massol, Jacques.
Afiliação
  • Fotso Kamdem A; Department of Pediatric Surgery, Besançon University Hospital, F-25000 Besançon, France. Electronic address: afotsokamdem@chu-besancon.fr.
  • Vidal C; INSERM-CIC-1431, Besançon University Hospital, F-25000 Besançon, France. Electronic address: c1vidal@chu-besancon.fr.
  • Pazart L; INSERM-CIC-1431, Besançon University Hospital, F-25000 Besançon, France. Electronic address: lpazart@chu-besancon.fr.
  • Leroux F; INSERM-CIC-1431, Besançon University Hospital, F-25000 Besançon, France. Electronic address: f1leroux@chu-besancon.fr.
  • Pugin A; INSERM-CIC-1431, Besançon University Hospital, F-25000 Besançon, France. Electronic address: avivot@chu-besancon.fr.
  • Savet C; Phisquare Institute, Transplantation Foundation, F-75015 Paris, France. Electronic address: c1marmier@chu-besancon.fr.
  • Sainte-Claire Deville G; Phisquare Institute, Transplantation Foundation, F-75015 Paris, France. Electronic address: geoffroy.sainteclairedeville.ext@aixial.com.
  • Guillemot D; INSERM UMR 1181 « Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases ¼ (B2PHI), F-75015 Paris, France; Institut Pasteur, UMR 1181, B2PHI, F-75015 Paris, France; University of Versailles St Quentin, UMR 1181, B2PHI, F-78180 Montigny-le-Bretonneux, France; AP-HP, Raymond Poinc
  • Massol J; Phisquare Institute, Transplantation Foundation, F-75015 Paris, France. Electronic address: jacques.massol.ext@aixial.com.
Vaccine ; 37(32): 4587-4593, 2019 07 26.
Article em En | MEDLINE | ID: mdl-30851968
OBJECTIVE: The objective of the present study was to investigate the risk factors for intussusception (IS) among infants, including vaccination against rotavirus. METHODS: Case-control study with systematic inclusion of all infants aged <1 year with suspected IS admitted to emergency departments in the eastern region of France between 1 April 2008 and 31 March 2012. All cases classed level 1 according to the Brighton classification were matched to 4 hospital controls. Two exposure windows were examined; exposure to the first dose of rotavirus vaccine in the 7 and in the 14 days prior to the occurrence of IS. RESULTS: A total of 115 cases were matched with 457 controls. The average vaccination coverage rate over the 4 years of study was 8.6%. Rotavirus vaccine was not found to be significantly associated with the occurrence of IS in the 7 days (odds ratio (OR) not calculated; p = 0.99) and in the 14 days after administration of one dose vaccine (OR 1.33, 95% confidence interval (CI) 0.14-12.82). Infant formula alone or combined with breastfeeding was associated with an excess risk of IS (OR 2.74, 95% CI 1.10-6.79). A history of gastroenteritis within 2 weeks prior to hospitalisation was also associated with an increased risk (OR 2.24, 95% CI 1.07-4.67). CONCLUSION: Our study indicates that infant formula alone or combined with breastfeeding is a risk factor for IS. A small, non-significant increase in the risk of IS was observed after rotavirus vaccination, although the low vaccine coverage rate likely precluded detection of a significant increase in risk.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinação / Vacinas contra Rotavirus / Intussuscepção Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinação / Vacinas contra Rotavirus / Intussuscepção Idioma: En Ano de publicação: 2019 Tipo de documento: Article